Literature DB >> 16046479

MARCKS is a major PKC-dependent regulator of calmodulin targeting in smooth muscle.

Cynthia Gallant1, Jae Young You, Yasuharu Sasaki, Zenon Grabarek, Kathleen G Morgan.   

Abstract

Calmodulin (CaM) is a ubiquitous transducer of intracellular Ca(2+) signals and plays a key role in the regulation of the function of all cells. The interaction of CaM with a specific target is determined not only by the Ca(2+)-dependent affinity of calmodulin but also by the proximity to that target in the cellular environment. Although a few reports of stimulus-dependent nuclear targeting of CaM have appeared, the mechanisms by which CaM is targeted to non-nuclear sites are less clear. Here, we investigate the hypothesis that MARCKS is a regulator of the spatial distribution of CaM within the cytoplasm of differentiated smooth-muscle cells. In overlay assays with portal-vein homogenates, CaM binds predominantly to the MARCKS-containing band. MARCKS is abundant in portal-vein smooth muscle ( approximately 16 microM) in comparison to total CaM ( approximately 40 microM). Confocal images indicate that calmodulin and MARCKS co-distribute in unstimulated freshly dissociated smooth-muscle cells and are co-targeted simultaneously to the cell interior upon depolarization. Protein-kinase-C (PKC) activation triggers a translocation of CaM that precedes that of MARCKS and causes multisite, sequential MARCKS phosphorylation. MARCKS immunoprecipitates with CaM in a stimulus-dependent manner. A synthetic MARCKS effector domain (ED) peptide labelled with a photoaffinity probe cross-links CaM in smooth-muscle tissue in a stimulus-dependent manner. Both cross-linking and immunoprecipitation increase with increased Ca(2+) concentration, but decrease with PKC activation. Introduction of a nonphosphorylatable MARCKS decoy peptide blocks the PKC-mediated targeting of CaM. These results indicate that MARCKS is a significant, PKC-releasable reservoir of CaM in differentiated smooth muscle and that it contributes to CaM signalling by modulating the intracellular distribution of CaM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046479     DOI: 10.1242/jcs.02493

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  15 in total

1.  Myristoylated alanine-rich C kinase substrate coordinates native TRPC1 channel activation by phosphatidylinositol 4,5-bisphosphate and protein kinase C in vascular smooth muscle.

Authors:  Jian Shi; Lutz Birnbaumer; William A Large; Anthony P Albert
Journal:  FASEB J       Date:  2013-09-10       Impact factor: 5.191

2.  Methionine oxidation in the calmodulin-binding domain of calcineurin disrupts calmodulin binding and calcineurin activation.

Authors:  Nicholas J Carruthers; Paul M Stemmer
Journal:  Biochemistry       Date:  2008-02-15       Impact factor: 3.162

3.  Cytoskeletal remodeling in differentiated vascular smooth muscle is actin isoform dependent and stimulus dependent.

Authors:  Hak Rim Kim; Cynthia Gallant; Paul C Leavis; Susan J Gunst; Kathleen G Morgan
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-02       Impact factor: 4.249

4.  Engineered Substrate-Specific Delta PKC Antagonists to Enhance Cardiac Therapeutics.

Authors:  Nir Qvit; Opher S Kornfeld; Daria Mochly-Rosen
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-17       Impact factor: 15.336

Review 5.  O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.

Authors:  Victor V Lima; Fernanda R Giachini; David M Hardy; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-10       Impact factor: 3.619

6.  B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ.

Authors:  Elisabeth Salzer; Elisangela Santos-Valente; Stefanie Klaver; Sol A Ban; Wolfgang Emminger; Nina Kathrin Prengemann; Wojciech Garncarz; Leonhard Müllauer; Renate Kain; Heidrun Boztug; Andreas Heitger; Klaus Arbeiter; Franz Eitelberger; Markus G Seidel; Wolfgang Holter; Arnold Pollak; Winfried F Pickl; Elisabeth Förster-Waldl; Kaan Boztug
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

7.  Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis.

Authors:  Pedro Echave; Gisela Machado-da-Silva; Rebecca S Arkell; Michael R Duchen; Jake Jacobson; Richard Mitter; Alison C Lloyd
Journal:  J Cell Sci       Date:  2009-11-17       Impact factor: 5.285

8.  Neuroprotective effects of new protein kinase C activator TPPB against Aβ₂₅₋₃₅ induced neurotoxicity in PC12 cells.

Authors:  Hong-Qi Yang; Xue Li; Wei-Min Yang; Shu-Man Feng; Jian-Jun Ma
Journal:  Neurochem Res       Date:  2012-07-26       Impact factor: 3.996

9.  MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein.

Authors:  Thomas S Monahan; Nicholas D Andersen; Michelle C Martin; Junaid Y Malek; Gautam V Shrikhande; Leena Pradhan; Christiane Ferran; Frank W LoGerfo
Journal:  FASEB J       Date:  2008-10-21       Impact factor: 5.191

Review 10.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.

Authors:  Zhongwei Liu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.